Evidence map›Paper›PMID 25755294›Full record

ArticleMolecular & cellular proteomics : MCP2015

An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood.

Siyang Li, Brian D Plouffe, Arseniy M Belov, Somak Ray, Xianzhe Wang, Shashi K Murthy, Barry L Karger, Alexander R Ivanov

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 155 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. StageTip: a little giant unveiling the potential of mass spectrometry-based proteomics.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Siyang LiFrom the ‡Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts; §Department of Chemical Engineering, Northeastern University, Boston, Massachusetts.
Brian D PlouffeFrom the ‡Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts; ¶Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts;
Arseniy M BelovFrom the ‡Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts; §Department of Chemical Engineering, Northeastern University, Boston, Massachusetts.
Somak RayFrom the ‡Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts;
Xianzhe WangFrom the ‡Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts; §Department of Chemical Engineering, Northeastern University, Boston, Massachusetts.
Shashi K MurthyFrom the ‡Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts; ¶Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts;
Barry L KargerFrom the ‡Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts; §Department of Chemical Engineering, Northeastern University, Boston, Massachusetts a.ivanov@neu.edu b.karger@neu.edu.
Alexander R IvanovFrom the ‡Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts; §Department of Chemical Engineering, Northeastern University, Boston, Massachusetts a.ivanov@neu.edu b.karger@neu.edu.
Northeastern University · USEastern University · BD

Funding

STUDIES IN HIGH PERFORMANCE LIQUID CHROMATOGRAPHYR01GM015847 · NIGMS · NORTHEASTERN UNIVERSITY · PI KARGER, BARRY L. · 1985 to 2013
$5.7M
MECHANISTIC STUDIES OF THE HYDROLYSIS OF NUCLEOSIDESF32GM015847 · NIGMS · UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS · PI MRACHKO, GREGORY T · 1993 to 1994
–
HPLC AND HPCE OF PROTEINSR37GM015847 · NIGMS · NORTHEASTERN UNIVERSITY · PI KARGER, BARRY L. · 1990 to 1999
–
NIGMS NIH HHS F32 GM015847NIGMS NIH HHS GM15847NIGMS NIH HHS R01 GM015847NIGMS NIH HHS R37 GM015847
6 · The paper itself

Abstract

Isolation and molecular characterization of rare cells (e.g. circulating tumor and stem cells) within biological fluids and tissues has significant potential in clinical diagnostics and personalized medicine. The present work describes an integrated platform of sample procurement, preparation, and analysis for deep proteomic profiling of rare cells in blood. Microfluidic magnetophoretic isolation of target cells spiked into 1 ml of blood at the level of 1000-2000 cells/ml, followed by focused acoustics-assisted sample preparation has been coupled with one-dimensional PLOT-LC-MS methodology. The resulting zeptomole detection sensitivity enabled identification of ∼4000 proteins with injection of the equivalent of only 100-200 cells per analysis. The characterization of rare cells in limited volumes of physiological fluids is shown by the isolation and quantitative proteomic profiling of first MCF-7 cells spiked into whole blood as a model system and then two CD133+ endothelial progenitor and hematopoietic cells in whole blood from volunteers.

Indexed as

HumansMass SpectrometryMCF-7 CellsMicrofluidicsProteomicsStem Cells

Identifiers

PMID25755294
PMCPMC4458728
OpenAlexW2171508380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.